FDA Approved: GABAPENTIN — Supplemental Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for gabapentin filed by Laurus Labs Limited, indicating a post-approval labeling change or related update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)